View in EDS HTML Full Text PDF Full Text

Cost effectiveness of mosunetuzumab and CAR-T cell therapy in relapsed/refractory follicular lymphoma.

Saved in:
Bibliographic Details
Title: Cost effectiveness of mosunetuzumab and CAR-T cell therapy in relapsed/refractory follicular lymphoma.
Authors: Lin, Meng-Hsuan1 (AUTHOR), Weiss, Jonathan2 (AUTHOR), Phillips, Tycel J.3 (AUTHOR), Sano, Dahlia2 (AUTHOR), Carty, Shannon A.2 (AUTHOR), Wilcox, Ryan2 (AUTHOR), Ghosh, Monalisa2 (AUTHOR), Ahmed, Iman2 (AUTHOR), Nachar, Victoria R.2 (AUTHOR), Hutton, David1 (AUTHOR), Karimi, Yasmin H.2 (AUTHOR) karimiy@med.umich.edu
Source: Leukemia & Lymphoma. Oct2025, Vol. 66 Issue 10, p1850-1862. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2025.2506498